Trial intelligence / Profile preview

Topical isotretinoin after rhinoplasty in patients with thick oily nasal skin

IRCT20180217038763N3Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of isotretinoin in post-rhinoplasty recovery (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Nasal edema and Ecchymosis. Started Oct 2021; status: completed.

02

Drugs

isotretinoin
03

Conditions

post-rhinoplasty recovery

Beyond the preview

Go deeper on IRCT20180217038763N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180217038763N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call